These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3059078)

  • 61. Mobile phospholipid signals in NMR spectra of cultured human adenocarcinoma cells.
    Guidoni L; Mariutti G; Rampelli GM; Rosi A; Viti V
    Magn Reson Med; 1987 Dec; 5(6):578-85. PubMed ID: 3437819
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts.
    Esmaeili M; Moestue SA; Hamans BC; Veltien A; Kristian A; Engebråten O; Maelandsmo GM; Gribbestad IS; Bathen TF; Heerschap A
    J Magn Reson Imaging; 2015 Mar; 41(3):601-9. PubMed ID: 24532410
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity, and apoptotic index.
    Kristensen CA; Kristjansen PE; Brünner N; Quistorff B; Spang-Thomsen M
    Cancer Res; 1995 Sep; 55(18):4146-50. PubMed ID: 7664292
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
    Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
    J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ex vivo 1H and 31P magnetic resonance spectroscopy as a means for tumor characterization in ovarian cancer patients.
    Abramov Y; Carmi S; Anteby SO; Ringel I
    Oncol Rep; 2013 Jan; 29(1):321-8. PubMed ID: 23042519
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 31P MRS of human tumor cells: effects of culture media and conditions on phospholipid metabolite concentrations.
    Franks SE; Kuesel AC; Lutz NW; Hull WE
    Anticancer Res; 1996; 16(3B):1365-74. PubMed ID: 8694503
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders.
    Argov Z; Bank WJ
    Ann Neurol; 1991 Jul; 30(1):90-7. PubMed ID: 1834009
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.
    Kristensen CA; Askenasy N; Jain RK; Koretsky AP
    Br J Cancer; 1999 Jan; 79(2):278-85. PubMed ID: 9888469
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Magnetic Resonance Spectroscopy (MRS)-Based Methods for Examining Cancer Metabolism in Response to Oncogenic Kinase Drug Treatment.
    Chung YL
    Methods Mol Biol; 2017; 1636():393-404. PubMed ID: 28730493
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Monitoring tumor response to therapy by means of 31P magnetic resonance spectroscopy. A case of advanced prostatic cancer with metastatic chest wall tumor].
    Kaneko H; Nakauchi K; Mashima Y; Kawakami M; Kumakawa T
    Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):819-22. PubMed ID: 8022147
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy.
    Merchant TE; Kasimos JN; de Graaf PW; Minsky BD; Gierke LW; Glonek T
    Int J Colorectal Dis; 1991 May; 6(2):121-6. PubMed ID: 1875121
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increase of GPC levels in cultured mammalian cells during acidosis. A 31P MR spectroscopy study using a continuous bioreactor system.
    Galons JP; Job C; Gillies RJ
    Magn Reson Med; 1995 Mar; 33(3):422-6. PubMed ID: 7760711
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alterations of membrane phospholipid metabolism in patients with schizophrenia assessed by phosphorus magnetic resonance spectroscopy.
    George TP; Spence MW
    Arch Gen Psychiatry; 1996 Nov; 53(11):1065-6. PubMed ID: 8911233
    [No Abstract]   [Full Text] [Related]  

  • 74. The effect of gossypol and 6-aminonicotinamide on tumor cell metabolism: a 31P-magnetic resonance spectroscopic study.
    Keniry MA; Hollander C; Benz CC
    Biochem Biophys Res Commun; 1989 Oct; 164(2):947-53. PubMed ID: 2530981
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human brain-dead donors and 31P MRS studies on feline myocardial energy metabolism.
    Brandon Bravo Bruinsma GJ; van Echteld CJ
    Adv Exp Med Biol; 2004; 550():197-205. PubMed ID: 15053438
    [No Abstract]   [Full Text] [Related]  

  • 76. Phospholipid metabolites as indicators of cancer cell function.
    Ruiz-Cabello J; Cohen JS
    NMR Biomed; 1992; 5(5):226-33. PubMed ID: 1449961
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Esophageal cancer phospholipids correlated with histopathologic findings: a 31P NMR study.
    Merchant TE; Minsky BD; Lauwers GY; Diamantis PM; Haida T; Glonek T
    NMR Biomed; 1999 Jun; 12(4):184-8. PubMed ID: 10421909
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Imaging intratumoral convection: pressure-dependent enhancement in chemotherapeutic delivery to solid tumors.
    Gade TP; Buchanan IM; Motley MW; Mazaheri Y; Spees WM; Koutcher JA
    Clin Cancer Res; 2009 Jan; 15(1):247-55. PubMed ID: 19118052
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy.
    Raghunand N; Altbach MI; van Sluis R; Baggett B; Taylor CW; Bhujwalla ZM; Gillies RJ
    Biochem Pharmacol; 1999 Feb; 57(3):309-12. PubMed ID: 9890558
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monitoring intracellular metabolism by nuclear magnetic resonance.
    Cohen JS; Lyon RC; Daly PF
    Methods Enzymol; 1989; 177():435-52. PubMed ID: 2607991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.